Who We Are?

News Times-HD proudly stands at the forefront of Pakistan’s news websites, offering an unswerving commitment to delivering real-time, pinpoint-accurate coverage across the spectrum of current affairs, business analytics, sports fervor, cutting-edge tech revelations, and groundbreaking health insights. Our exceptional team of seasoned journalists and astute analysts works tirelessly to ensure you are consistently updated with the latest news and global events, sourced from both Pakistan and around the world. Our paramount objective is to keep our readers not only informed but fervently engaged with the ever-evolving world that surrounds them.

Developed By ASK

Tag: Bristol-Myers Squibb Co

Bristol Myers Squibb results top estimates as new drugs post strong sales growth

Fourth-quarter earnings are shaping up to be the best of 2023, but there’s a catch

Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

LATEST POSTS

India’s Iyer discharged from hospital after spleen injury

Need to carve new pathways

Sean ‘Diddy’ Combs faces new disturbing allegation involving Biggie Smalls

POPULAR CATEGORY

POPULAR POSTS

Emergency Contraceptive Pill: 7 side effects of morning-after pill which are important to know |

Stand-up comic Becky Robinson’s viral wine-mom character leads to sold-out shows and a fan golf tournament

Tata Motors, M&M, Kia, TVS: Auto Sales Shift Into Top Gear In October On Festive Cheer, GST Cuts

Who We Are?